ATE37185T1 - Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern. - Google Patents
Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern.Info
- Publication number
- ATE37185T1 ATE37185T1 AT84300611T AT84300611T ATE37185T1 AT E37185 T1 ATE37185 T1 AT E37185T1 AT 84300611 T AT84300611 T AT 84300611T AT 84300611 T AT84300611 T AT 84300611T AT E37185 T1 ATE37185 T1 AT E37185T1
- Authority
- AT
- Austria
- Prior art keywords
- norgestrel
- levo
- esters
- oxime
- compositions based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB838313921A GB8313921D0 (en) | 1983-05-19 | 1983-05-19 | Contraceptive compositions |
EP84300611A EP0129947B1 (de) | 1983-05-19 | 1984-01-31 | Kontrazeptive Zusammensetzungen auf Basis von Levo-Norgestrel-Estern |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE37185T1 true ATE37185T1 (de) | 1988-09-15 |
Family
ID=10543055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT84300611T ATE37185T1 (de) | 1983-05-19 | 1984-01-31 | Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0129947B1 (de) |
AT (1) | ATE37185T1 (de) |
DE (1) | DE3474024D1 (de) |
GB (1) | GB8313921D0 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3511588A1 (de) * | 1985-03-27 | 1986-10-02 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Waessrige kristallsuspension von steroidglykoestern |
DE4232521A1 (de) * | 1992-09-22 | 1994-03-24 | Schering Ag | Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln |
EP1098653A2 (de) * | 1998-07-17 | 2001-05-16 | PHARMACIA & UPJOHN COMPANY | Subkutane verabreichung von medroxyprogesteronacetat zur kontrazeption |
TW200403065A (en) * | 2002-05-30 | 2004-03-01 | Akzo Nobel Nv | New etonogestrel esters |
EP2399566A1 (de) * | 2010-06-28 | 2011-12-28 | Laboratoire HRA Pharma | Verfahren zur Empfängnisverhütung einmal im Monat |
WO2017147274A1 (en) * | 2016-02-24 | 2017-08-31 | Eastern Virginia Medical School | An improved formulation of long-acting levonorgestrel butanoate injectable depot suspension |
PE20210155A1 (es) * | 2017-10-19 | 2021-01-26 | Evestra Inc | Anticonceptivos de profarmacos de progestina de accion mas prolongada |
US11186585B2 (en) * | 2018-08-17 | 2021-11-30 | Kappa-Pharma LLC | Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4027019A (en) * | 1975-07-24 | 1977-05-31 | Ortho Pharmaceutical Corporation | 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method |
-
1983
- 1983-05-19 GB GB838313921A patent/GB8313921D0/en active Pending
-
1984
- 1984-01-31 DE DE8484300611T patent/DE3474024D1/de not_active Expired
- 1984-01-31 EP EP84300611A patent/EP0129947B1/de not_active Expired
- 1984-01-31 AT AT84300611T patent/ATE37185T1/de active
Also Published As
Publication number | Publication date |
---|---|
EP0129947B1 (de) | 1988-09-14 |
EP0129947A3 (en) | 1985-05-22 |
GB8313921D0 (en) | 1983-06-22 |
DE3474024D1 (en) | 1988-10-20 |
EP0129947A2 (de) | 1985-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO944113L (no) | Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering | |
HUT37418A (en) | Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents | |
ATE61050T1 (de) | Pyridazinamine wirksam gegen viren. | |
HUT61324A (en) | Process for producing rhombic cyclosporin consisting of globular particles and new pulmonary pharmaceutical compositions comprising same as active ingredient | |
PT1086688E (pt) | Formulacoes de aerossol em suspensao | |
DE69430635D1 (de) | Loteprednoletabonat-suspension | |
ES2055014T3 (es) | Productos que contienen psyllium. | |
HUT41957A (en) | Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents | |
ATE37185T1 (de) | Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern. | |
HUT47793A (en) | Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components | |
DK0667155T3 (da) | Tabletter med thioctsyre med bestemt kornstørrelse | |
HUT61024A (en) | Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient | |
UA74388C2 (uk) | Фармацевтичні композиції тизоксаніду і нітазоксаніду | |
CA2047802A1 (en) | Pharmaceutical compositions | |
TW325404B (en) | Pharmaceutical composition for the safe administration of fatty acids the invention relates to a pharmaceutical composition for the safe administration of fatty acids which is useful in the treatment of cancer, viral infections and other disorders. | |
HUT63306A (en) | Insecticidal compositions comprising guanide derivatives as active ingredient and process for producing the active ingredient | |
ES8504774A1 (es) | Procedimiento para preparar derivados de 2-piperacinil-quinazolina | |
HUT41376A (en) | Insecticide compositions containing phenyl-hidrazine derivatives as active agents and process for producing the active agents | |
HUT47792A (en) | Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components | |
FR2515038B1 (fr) | A titre de medicaments, certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant | |
IL111138A (en) | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia | |
FR2556592B1 (fr) | Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique | |
HUT50807A (en) | Process for producing pharmaceutical compositions comprising labdane derivatives as active ingredient and for producing the active ingredient | |
CA2073673A1 (en) | Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors | |
EP0141414A3 (de) | Haartonikum-Präparat |